Eli Lilly

News

Lilly doubles down on Irish plant, ups spend to near $1bn

Eli Lilly's close ties to Ireland’s pharma manufacturing sector have just got even stronger, after the US pharma announced plans to double its planned investment in a new

News

Novartis preps key early breast cancer filing for Kisqali

NATALEE trial readout sets up Kisqali as rival to Lilly's Verzenio as adjuvant treatment.

News

Roche, Lilly join forces on blood test for Alzheimer’s

If approved, EAPP could help streamline the journey to diagnosis for patients, say partners.

News

$AbbVie’s Skyrizi hits the spot in refractory psoriasis$

AbbVie’s Skyrizi hits the spot in refractory psoriasis

Antibody works when IL-17 inhibitors Like Novartis' Cosentyx and Lilly's Taltz fail.

News

FDA removes leash from Verzenio in early breast cancer

Drug can now be used as adjuvant therapy without Ki-67 testing, taking a brake off prescribing.

News

Lilly adds to non-opioid pain pipeline with Confo deal

Deal covers an AT2R inhibitor, a class that has been plagued by safety and efficacy issues.

Lilly doubles down on Irish plant, ups spend to near $1bn

Novartis preps key early breast cancer filing for Kisqali

Roche, Lilly join forces on blood test for Alzheimer’s

AbbVie’s Skyrizi hits the spot in refractory psoriasis

FDA removes leash from Verzenio in early breast cancer

Lilly adds to non-opioid pain pipeline with Confo deal

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

Eli Lilly

Editor's Picks